Corticosteroids for COVID-19: living guidance, WHO

The role of systemic corticosteroids in the treatment of patients with COVID-19. This guideline was triggered on 22 June 2020 by the publication of the preliminary report of the RECOVERY trial, which has now been published as a peer-reviewed paper. Corticosteroids are listed in the World Health Organization (WHO) model list of essential medicines, readily available globally at a low cost, and of considerable interest to all stakeholder groups.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news